Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.56M Sell
52,020
-5,186
-9% -$121K ﹤0.01% 2368
2025
Q4
$1.3M Buy
57,206
+2,476
+5% +$66.8K ﹤0.01% 2483
2025
Q3
$1.52M Buy
54,730
+529
+1% +$16.6K ﹤0.01% 2417
2025
Q2
$1.98M Sell
54,201
-1,253
-2% -$58.5K ﹤0.01% 2303
2025
Q1
$2.34M Buy
55,454
+21,687
+64% +$1.27M ﹤0.01% 2276
2024
Q4
$2.2M Buy
33,767
+13,170
+64% +$915K ﹤0.01% 2351
2024
Q3
$1.27M Sell
20,597
-19,828
-49% -$1.2M ﹤0.01% 2648
2024
Q2
$3.04M Buy
+40,425
New +$3.77M ﹤0.01% 2181

Other funds holding IBTA

Nuveen's IBTA Position: Q1 2026 in Review

Nuveen reduced its Ibotta (IBTA) stake by 9.1% in Q1 2026, selling an estimated $121K and leaving 52,020 shares worth $1.56M. The position accounts for ﹤0.01% of the portfolio, ranked #2368.

Nuveen first reported a position in IBTA in Q2 2024 and has held it in 8 quarters since. The position peaked at $3.04M in Q2 2024. 132 funds tracked by Wall St. Rank hold IBTA as of Q1 2026.

  • Nuveen held 52,020 shares of Ibotta worth $1.56M as of Q1 2026.
  • Nuveen sold 5,186 Ibotta shares in Q1 2026, an estimated $121K.
  • Ibotta made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #2368 holding.
  • Nuveen first reported a position in Ibotta in Q2 2024 and has held it in 8 quarters since.
  • Nuveen's Ibotta position peaked at $3.04M in Q2 2024.
  • 132 funds tracked by Wall St. Rank held Ibotta as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.